Expressions of SUMO4, NF-κB and IκB in kidney of rats with type 2 diabetes mellitus and its significance
1008-0074. 2012.01.01
- VernacularTitle:SUMO4、NF-κB、IκB在2型糖尿病大鼠肾脏中的表达及意义
- Author:
Sijiao CHEN
;
Danan WANG
;
Jinchun XU
;
Hongyan LI
;
Furong LIU
;
Jindan SONG
- Publication Type:Journal Article
- Keywords:
Small ubiquitin-related modifier proteins, Transcription factor;
Diabetes mellitus, type 2;
Rats
- From:
Chinese Journal of cardiovascular Rehabilitation Medicine
2012;21(1):1-5
- CountryChina
- Language:English
-
Abstract:
Objective: To study expressions of small ubiquitin-related modifier protein（SUMO）4 (SUMO4), nuclear factor (NF)- κB and inhibitory factor of NF-κB (IκB) in kidneys of rats with type 2 diabetes mellitus (T2DM). Methods: A total of ten 40-week-old male Goto-Kakizaki (GK) rats （with spontaneous diabetes mellitus）of specific-pathogen free (SPF) grade, and ten 40-week-old male Wistar rats of SPF grade were selected. The lesion of renal tissue was observed by hematoxylin eosin (HE) staining. Expressions of SUMO4, NF-κB and IκB in renal tissue were observed by immunohistochemistry methods. Results: In the GK rats, glomerular capillary ball hypertrophy, basilar membrane slightly thickening; glomerular mesangial cells hyperplasia, hypertrophy and renal tubular epithelial cells hypertrophy were observed. Compared with normal Wistar rats, expression levels of NF-κB [(0.232±0.034) vs. (0.634±0.058)], IκB [(0.242±0.027) vs. (0.712±0.078)] and SUMO4 [(0.160±0.031) vs. (0.545±0.045)] significantly increased in renal tissue of GK rats (P<0.01 all). Conclusion: Compared with Wistar rats, expressions of NF-κB, IκB and SUMO4 significantly increase in renal tissue of GK rats, suggesting that SUMO inhibiting transcriptional activity of NF-κB may exist in kidneys of T2DM rats. Therefore, sumoylation may be a new therapeutic target for inhibit renal microvascular lesion of diabetic disease.
- Full text:P020120303830811078162.doc
